Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Biote Q1 2024 GAAP EPS $(0.06) Misses $0.03 Estimate, Sales $46.804M Beat $45.711M Estimate

Author: Benzinga Newsdesk | May 07, 2024 05:48pm
Biote (NASDAQ:BTMD) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $0.03 by 300 percent. This is a 84.62 percent increase over losses of $(0.39) per share from the same period last year. The company reported quarterly sales of $46.804 million which beat the analyst consensus estimate of $45.711 million by 2.39 percent. This is a 4.37 percent increase over sales of $44.843 million the same period last year.

Posted In: BTMD